We’re sitting down to have an honest, nuanced conversation about Ozempic (semaglutide), other GLP-1 drugs, and their role in lifestyle intervention and health. We want to understand who benefits, who profits, and what the implications are for individuals, coaches, and the broader CrossFit community. 

The goal is not to provide all the answers or be the experts, but to create space for a thoughtful discussion around an important and highly visible issue, especially in light of GLP-1 provider Ro’s recent sponsored post featuring Serena Williams. 

Host Denise Thomas is joined by Dr. Tom McCoy, Jocelyn Rylee, and Joe Alexander. 

Let us know what you think –> [email protected]

Follow us on YouTube to join future livestreams.